The next generation transcatheter pVAD
VenstraMedical is a medical device startup bringing an advanced percutaneous ventricular assist device (pVAD) capable of pumping 7 liter/min at 60mmHg of pressure in a collapsible, 9F delivery approach.
The Complete pVAD Solution
In the News
VenstraMedical announces it has secured a portion of its capital raise goal from HighCroft Capital. These proceeds, when rounded out from additional investors, will accelerate development of the companies novel pVAD system.
There's no better validation of our development efforts at VenstraMedical than to get featured in Forbes Magazine! We are eager to get our technology to those who could benefit …
VenstraMedical is proud to be featured in the American Society for Artificial Organs (ASAIO) Journal highlighting the pre-clinical testing of our novel pVAD platform…